Omeros Set for Potential Breakout Ahead of FDA Decision
AI Prediction of Omeros Corporation (OMER)
Omeros, with its significant clinical developments and recent financial restructuring, appears poised for potential growth. The expected FDA decisions and advancements in clinical trials for narsoplimab and other pipeline assets could serve as significant catalysts for stock price movement.
OMER Report Information
Prediction Date2025-07-03
Close @ Prediction$3.20
Mkt Cap632m
IPO DateN/a
AI-derived Information
Recent News for OMER
- May 14, 8:30 am — Omeros Corporation Q1 2026 Earnings Call Summary (Moby)
- May 14, 1:02 am — Omeros Corp (OMER) Q1 2026 Earnings Call Highlights: Strong YARTEMLEA Launch and Strategic ... (GuruFocus.com)
- May 13, 4:17 pm — Omeros: Q1 Earnings Snapshot (Associated Press)
- May 13, 4:02 pm — Omeros Corporation Reports First Quarter 2026 Financial Results (Business Wire)
- May 11, 4:02 pm — Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026 (Business Wire)
- Apr 16, 8:45 am — CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA (narsoplimab-wuug) (Business Wire)
- Apr 10, 8:11 pm — Does Omeros (OMER) Have the Potential to Rally 266.67% as Wall Street Analysts Expect? (Quartz)
- Apr 1, 8:30 am — Omeros Corporation Q4 2025 Earnings Call Summary (Moby)
- Mar 31, 11:02 pm — Omeros Corp (OMER) Q4 2025 Earnings Call Highlights: A Turnaround with Strategic Deals and FDA ... (GuruFocus.com)
- Mar 31, 4:22 pm — Omeros: Q4 Earnings Snapshot (Associated Press)
- Mar 31, 4:02 pm — Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results (Business Wire)
- Mar 26, 8:45 am — Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026 (Business Wire)
Welcome to ScanScor. What you're reading is no ordinary summary -- it's the result of a carefully-crafted interactive session with OpenAI's most advanced models crafted from news, trial details, and financial data. This report attempts to maximize the potential for OpenAI's smartest GPT-based analysis engine, guided by tightly structured prompts to expose the forces behind today's market movers and to predict the future.
Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.
Well, today OMER had a major breakthrough, and surpassed the predicted high, but about 5 days late. This could be partly due to the government shutdown.